Efficacy and safety of LY01005 versus goserelin implant in Chinese patients with prostate cancer: A multicenter, randomized, open-label, phase III, non-inferiority trial.
- DOI
- 10.1097/cm9.0000000000002638
- Published
- 2023 May 20
- Container
- Chinese medical journal
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1097/cm9.0000000000002638,
title = {Efficacy and safety of LY01005 versus goserelin implant in Chinese patients with prostate cancer: A multicenter, randomized, open-label, phase III, non-inferiority trial.},
author = {Gu C and Wang Z and Lin T and Liu Z and Han W and Zhang X and Liang C and Liu H and Yu Y and Xu Z and Liu S and Wang J and Jia L and Yao X and Liao W and Fu C and Tan Z and He G and Zhu G and Fan R and Yang W and Chen X and Liu Z and Zhong L and Shi B and Ding D and Chen S and Wei J and Yao X and Chen M and Lu Z and Xie Q and Hu Z and Wang Y and Guo H and Fan T and Liang Z and Chen P and Wang W and Xu T and Li C and Xing J and Liao H and He D and Wu Z and Yu J and Feng Z and Yang M and Dou Q and Zeng Q and Li Y and Gou X and Zhou G and Wang X and Zhu R and Zhang Z and Zhang B and Tan W and Qu X and Sun H and Gan T and Ye D},
year = {2023},
journal = {Chinese medical journal},
doi = {10.1097/cm9.0000000000002638},
url = {https://doi.org/10.1097/cm9.0000000000002638}
}RIS
TY - JOUR TI - Efficacy and safety of LY01005 versus goserelin implant in Chinese patients with prostate cancer: A multicenter, randomized, open-label, phase III, non-inferiority trial. AU - Gu C AU - Wang Z AU - Lin T AU - Liu Z AU - Han W AU - Zhang X AU - Liang C AU - Liu H AU - Yu Y AU - Xu Z AU - Liu S AU - Wang J AU - Jia L AU - Yao X AU - Liao W AU - Fu C AU - Tan Z AU - He G AU - Zhu G AU - Fan R AU - Yang W AU - Chen X AU - Liu Z AU - Zhong L AU - Shi B AU - Ding D AU - Chen S AU - Wei J AU - Yao X AU - Chen M AU - Lu Z AU - Xie Q AU - Hu Z AU - Wang Y AU - Guo H AU - Fan T AU - Liang Z AU - Chen P AU - Wang W AU - Xu T AU - Li C AU - Xing J AU - Liao H AU - He D AU - Wu Z AU - Yu J AU - Feng Z AU - Yang M AU - Dou Q AU - Zeng Q AU - Li Y AU - Gou X AU - Zhou G AU - Wang X AU - Zhu R AU - Zhang Z AU - Zhang B AU - Tan W AU - Qu X AU - Sun H AU - Gan T AU - Ye D PY - 2023 JO - Chinese medical journal DO - 10.1097/cm9.0000000000002638 UR - https://doi.org/10.1097/cm9.0000000000002638 ER -
APA
C, G., Z, W., T, L., Z, L., W, H., X, Z., C, L., H, L., Y, Y., Z, X., S, L., J, W., L, J., X, Y., W, L., C, F., Z, T., G, H., G, Z., R, F., W, Y., X, C., Z, L., L, Z., B, S., D, D., S, C., J, W., X, Y., M, C., Z, L., Q, X., Z, H., Y, W., H, G., T, F., Z, L., P, C., W, W., T, X., C, L., J, X., H, L., D, H., Z, W., J, Y., Z, F., M, Y., Q, D., Q, Z., Y, L., X, G., G, Z., X, W., R, Z., Z, Z., B, Z., W, T., X, Q., H, S., T, G., & D, Y. (2023). Efficacy and safety of LY01005 versus goserelin implant in Chinese patients with prostate cancer: A multicenter, randomized, open-label, phase III, non-inferiority trial.. Chinese medical journal. https://doi.org/10.1097/cm9.0000000000002638
Source records
- pubmed · retrieved 2026-09-26T21:06:32.038Z